Oscillating Positive Expiratory Pressure Devices Market
Oscillating Positive Expiratory Pressure Devices Market to reach US$ 208.9 Mn by 2032, driven by increasing prevelance of COPD in emerging countries: Global Insight Services
New York, July 2023: According to a new research study by Global Insight Services (GIS), the global Oscillating Positive Expiratory Pressure Devices market is expected to grow rapidly over the next 10 years to reach a value of more than the US $ 208.9 Mn by 2032.
The machines that are utilized to remove secretions from the airways are known as oscillating positive expiratory pressure (OPEP) devices. People with chronic respiratory conditions like COPD, cystic fibrosis, and chronic bronchitis among others can benefit from it. The device is used to remove excess mucus that these illnesses produce. It facilitates breathing and helps to relax the lungs’ walls.
Request Sample Pages of this Research Report:
https://www.globalinsightservices.com/request-sample/GIS10444/
Oscillating Positive Expiratory Pressure Devices Market: Key Trends and Drivers
The increasing prevalence of cystic fibrosis and chronic obstructive pulmonary disease (COPD) has led to a surge in demand for mucous clearing devices, with oscillating positive expiratory pressure (OPEP) devices spearheading the growth of the market. These conditions often result in the accumulation of thick mucus in the airways, leading to breathing difficulties and decreased lung function. OPEP devices offer an effective solution by generating oscillations during exhalation, which helps to mobilize and loosen the mucus, facilitating its removal and improving airway clearance. As awareness of the benefits of these devices continues to spread among healthcare professionals and patients alike, the OPEP devices market is poised to experience significant expansion to meet the rising needs of individuals seeking better management of cystic fibrosis and COPD.
Oscillating Positive Expiratory Pressure Devices Market: Restraints & Challenges
The oscillating positive expiratory pressure (OPEP) devices market is facing challenges in its growth trajectory, primarily due to two key factors: low awareness and high cost. Despite the potential benefits these devices offer in improving respiratory health, there remains a lack of sufficient awareness among healthcare professionals and patients alike. This limited awareness hampers the adoption of OPEP devices, as potential users may not fully understand their advantages. Moreover, the relatively high cost associated with these devices also acts as a significant restraint on market growth, making them less accessible to a broader population. To overcome these obstacles, concerted efforts are required from manufacturers and healthcare stakeholders to increase awareness through educational initiatives, while also exploring avenues to make these devices more cost-effective and affordable to a consumers.
Oscillating Positive Expiratory Pressure Devices Market Report Findings
The mouthpiece PEP device segment is likely to hold a dominant Oscillating Positive Expiratory Pressure Devices market share and grow at a substantial CAGR during the forecast period.
Based on the product type, it is segmented into face mask PEP devices, mouthpiece PEP devices, and bottle PEP devices. The mouthpiece PEP devices segment is anticipated to dominate the market during the forecast period. These innovative devices have garnered widespread attention and adoption among patients with respiratory conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The mouthpiece PEP devices offer several advantages, including enhanced portability, ease of use, and improved patient compliance compared to traditional mask-based PEP devices. Moreover, their ability to effectively mobilize mucus, improve lung function, and reduce the risk of respiratory infections has further fueled their popularity. As healthcare providers and patients increasingly recognize the benefits of mouthpiece PEP devices, their rising demand is expected to drive remarkable growth in the oscillating PEP devices market, ultimately revolutionizing respiratory care and management for those in need.
The COPD & Asthma segment is anticipated to hold a majority of the Oscillating Positive Expiratory Pressure Devices market size throughout the study period.
Based on the indication, it is segmented into COPD & asthma, bronchitis, cystic fibrosis, and others. The COPD & Asthma segment is anticipated to dominate the market during the forecast period. Due to the primary reason of tobacco use, COPD is brought on by airway blockage that makes breathing difficult. The third leading cause of death worldwide in 2019 is a chronic obstructive pulmonary disease, according to a report from the World Health Organization. Over the projected period, the segment’s growth is anticipated to be boosted by increasing patient awareness of the need to create a unified platform for COPD sufferers. For instance, worldwide, November is recognized as National COPD Month. The COPD (chronic obstructive pulmonary disease) Foundation teams up with a number of respiratory healthcare organizations to organize a number of online and offline events for COPD community members to increase exposure. heance, all such factor will fuel the segment as well as market growth.
The hospitals & clinics segment is anticipated to hold a majority of the Oscillating Positive Expiratory Pressure Devices market size throughout the study period.
Based on end user, it is segmented into hospital & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment is anticipated to dominate the market during the forecast period. Hospital oscillating positive expiratory pressure (OPEP) devices are expected to be more in demand as a result of the increase of hospitals, especially in developed countries. Furthermore, the segment’s growth is supported by the presence of a well-developed infrastructure and the availability of cutting-edge equipment. Additionally, as more patients are admitted to hospitals, these devices are used more frequently, which boosts revenue in hospital pharmacies.
Moreover, increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis has led to a rise in the demand for effective airway clearance devices in medical settings. OPEP devices have gained popularity in hospitals and clinics due to their ability to help patients clear mucus from their airways, improve lung function, and reduce the risk of exacerbations. Additionally, advancements in technology and the introduction of portable and user-friendly OPEP devices have further fueled their adoption in healthcare facilities. As a result, the hospital and clinics segment is expected to continue experiencing positive growth as healthcare providers recognize the importance of these devices in enhancing respiratory care and patient outcomes.
The Asia Pacific region is estimated to exhibit the highest growth rate during the Oscillating Positive Expiratory Pressure Devices market forecast period.
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American region is anticipated to dominate the market during the forecast period. Asthma affects 1 in 13 persons, according to a 2019 report from the Centers for Disease Control and Prevention (CDC). Asthma affects more than 25 million Americans. This represents 8.4% of kids and 7.7% of adults. All age, sex, and racial groups have shown an increase in asthma cases since the early 1980s. The American Academy of Allergy, Asthma and Immunology (AAAI) estimates that in 2016, 8.3% of American children were diagnosed with asthma. Boys had an overall higher prevalence of asthma than girls, with rates of 9.2% and 7.4%, respectively. Children’s asthma incidence rose from 8.7% in 2001 to 9.4% in 2010, then fell to 8.3% in 2016. Though not all adjustments were statistically significant. Thus, aforementioned factors will drive the market growth in North America during the forecast period.
Moreover, OPEP devices are increasingly recognized as effective respiratory therapy tools for patients with various pulmonary conditions, such as chronic obstructive pulmonary disease (COPD), asthma, and bronchiectasis. The rising prevalence of respiratory disorders, coupled with the growing geriatric population, has fueled the demand for these devices in the region. Additionally, advancements in technology, leading to the development of more user-friendly and portable OPEP devices, have further driven market adoption. Moreover, an increasing focus on home-based healthcare solutions and a growing emphasis on preventive care are likely to bolster the market’s expansion. As a result, key market players are investing in research and development activities to innovate and launch new OPEP devices, thereby contributing to the market’s growth in North America.
Have a question for our analyst:
https://www.globalinsightservices.com/inquiry-before-buying/GIS10444/
Competitive Landscape
The major players studied in the global oscillating positive expiratory pressure devices market are AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.
Recent Developments in the Oscillating Positive Expiratory Pressure Devices Market:
- In April 2021, Smiths Medical launched the acapella choice blue vibratory PEP therapy system. Acapella is designed to aid in removing secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
- In May 2021, Monaghan Medical Corporation and Captis announced their agreement to a three year contract creating a partnership between the industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold standard medical devices, with Captis’ desire to drive process efficiencies and value driven healthcare spending.
- In January 2021, AirPhysio, indicated for use as a Positive Expiratory Pressure (PEP) Device, received approval from the United States Food and Drug Administration.
- In February 2020, Smiths Medical Announced Launch Of Oscillatory Positive Expiratory Pressure Educational Programme On Doctors.net.uk.
Oscillating Positive Expiratory Pressure Devices Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Oscillating Positive Expiratory Pressure Devices Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of Oscillating Positive Expiratory Pressure Devices Market in terms of revenue ($Million).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Oscillating Positive Expiratory Pressure Devices industry.
- A thorough analysis of market trends and restraints is provided.
- By region as well as country market analysis is also presented in this report.
- Analytical depiction of the Oscillating Positive Expiratory Pressure Devices Market along with the current trends and future estimations to depict imminent investment pockets. The overall Oscillating Positive Expiratory Pressure Devices industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Oscillating Positive Expiratory Pressure Devices Market are also analyzed.
Global Oscillating Positive Expiratory Pressure Devices Market Segmentation
By Product Type
- Face Mask PEP Devices
- Mouthpiece PEP Devices
- Bottle PEP Devices
By Indication
- COPD & Asthma
- Bronchitis
- Cystic Fibrosis
- Others
By End User
- Hospital & Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The UK
- Germany
- France
- Spain
- Italy
- Netherlands
- Sweden
- Switzerland
- Denmark
- Finland
- Russia
- Rest of Europe
- The Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Taiwan
- Malaysia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa
Key Players